Survey: the future of bioanalysis for biologics development
Biologics encompass a wide range of therapeutics and drug products isolated from natural sources. Products such as vaccines, blood and blood components, allergenics, cells, genes, tissues and recombinant proteins isolated from human, animal or microorganism sources are all considered biologics.
Advantages of biologics over small molecules include high specificity and less off-target adverse effects. With an increased interest in biologics, the need for bioanalytical solutions and technologies supporting the quantification of biologics and biomarkers is also increasing.
This survey has now closed.
However, check out our infographic summarizing the results from this survey investigating and evaluating the analytical methods, innovative solutions, and technologies currently being used by the bioanalytical community.
Click here to access the infographic
In association with:
